Products for Research Use Only
RegisterLogin

Nepuvibart

CAT: 0804-HY-145643Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-145643Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Nepuvibart (ZRC3308-B10) is an anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Nepuvibart shows good binding affinity to a non-competing epitope on the RBD of the SARS-CoV-2 spike protein. Nepuvibart can be used in combination with ZRC3308-A7 at a ratio of 1:1, which is effective for the prevention of COVID-19 and the early stage of COVID-19 before the development of severe disease[1].
CAS Number
2640224-48-0
Product Name Alternative
ZRC3308-B10
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/nepuvibart.html
Solubility
10 mM in DMSO
Smiles
[Nepuvibart]
References & Citations
[1]Yadav PD, et al. ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection. Viruses. 2021 Dec 3;13 (12) :2424.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
T74425-01Nepuvibart
GTR18338049-01Nepuvibart Antibody
ICH5707-20mgNepuvibart Biosimilar - Research Grade
GTR18780189-01(Nepuvibart) Biosimilar Reference Antibody
MBS1564041-01Research Grade Nepuvibart
E55B0886Nepuvibart (Reference antibody)
GTR18697218-01Nepuvibart Human Monoclonal Antibody
A135618Nepuvibart Biosimilar (Monoclonal, IgG1, kappa)
RA0657-01Nepuvibart (Biosimilar Reference Antibody) (SARS-CoV-2 Spike RBD)
PX-TA1869-01Nepuvibart Biosimilar - Anti-SARS-CoV-2 Spike RBD mAb - Research Grade

Popular Products